Industries > Pharma > Medical Device Outsourcing Report 2019-2029

Medical Device Outsourcing Report 2019-2029

Analysis by Product (Finished goods, Electronics, Raw Materials), by Device Type (Class I Devices, Class II Devices, Class III Devices), by Application (Orthopaedics and Spine, Cardiovascular, Radiology, General Medical Devices, Others) and by Region (North America, Europe, Asia Pacific, Latin America, MEA), Company and Country Analysis and Forecasts

PUBLISHED: 21 June 2019
PAGES: 185
PRODUCT CODE: PHA0451
SUBMARKET: Digital Healthcare

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0451 Categories: , Tag:

Market Definition:
• A medical device is any instrument, software, implement, machine, appliance, apparatus, reagent for in vitro use, implant, material or other similar or related article, deliberated by the manufacturer to be used, alone or in combination, for human beings, for specific medical purposes.
• These devices benefit patients by providing them health care diagnose and treat and help them to control disease or sickness further improving their quality of life.

Market Overview and Trends
• With the rising demand for advanced products and increase in competition amongst the manufacturers is moving towards the development of products at lower cost.
• It can also be predicted that the growing inclination towards outsourcing services like product implementation, regulatory consulting and quality assurance can enlarge the medical device outsourcing market.
• Decreases in the overall cost, reduction in the time required by the manufacturers to take part in the market are some of the evidences of increase in the medical outsourcing market.
• The outsourcing also permits the companies to centre its interest on their main objectives such as marketing of the medical device.

Market Dynamics:

Factors Influencing the Market Growth:
• The factors driving the Global Medical Device Outsourcing markets are- Introduction of new and innovative products, rising costs for hospital and increasing demand of medical devices, need for cost effective products, and others. Several development programs held by Polymer Science and Engineering Department by the University of Massachusetts for the growth of medical device industry and also help to generate skilled workers.
• The increasing demand for medical devices along with the rising price competition and requirement to reduce cost is projected to drive the growth of the market during the forecast period.
• The changing regulatory landscape and increasing tendency towards outsourcing services for example, quality assurance, regulatory consulting, and product implementation are expected to the growth of market during the forecast period.

Factors Restraining the Market Growth:
• The factors restraining the market growth are the threat of loss of confidential information, constant cost pressures and reimbursement policies could affect the growth rate of the Global Medical Device Outsourcing market.

Market Segmentation 2019-2029:
The Global Medical Device Outsourcing market is segmented on the product, device type, application and region.

1. Global Medical Device Outsourcing, by Product
a) Finished goods
b) Electronics
c) Raw Materials

2. Global Medical Device Outsourcing, by Device Type
a) Class I Devices
b) Class II Devices
c) Class III Devices

3. Global Medical Device Outsourcing, by Application
a) Orthopaedics and Spine
b) Cardiovascular
c) Radiology
d) General Medical Devices
e) Others

4. Global Medical Device Outsourcing, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Celestica, Inc., Creganna, Flextronics International Ltd., Heraeus Holding, Integer Holdings Corporation, Nortech Systems, Inc., Plexus Corp., Sanmina Corporation, Tecomet, Inc., and West Pharmaceutical Services, Inc.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Medical Device Outsourcing Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Medical Device Outsourcing Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category